Genmab | GEN - Trade Creditors


Genmab reported DKK116M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Almirall EUR 235.53M 22.52M Jun/2026
Amarin USD 40.43M 21.63M Sep/2026
Amgen USD 2.86B 16.65B Jun/2026
argenx SE USD 719M 164.73M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bayer EUR 6.39B 192M Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Demant DKK 1.06B 134M Jun/2026
Exelixis USD 30.83M 8.23M Sep/2026
Fresenius Medical Care EUR 891.84M 1.41M Jun/2026
Genmab DKK 116M 110M Jun/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
GN Store Nord DKK 1.08B 69M Jun/2026
GRIFOLS EUR 1B 160M Jun/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Insmed USD 84.3M 9.75M Sep/2026
Lakefront Biotherapeutics EUR 66.35M 29.42M Jun/2026
Lonza CHF 471M 3M Dec/2024
Merck EUR 2.07B 61M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
UCB EUR 4.04B 755M Dec/2025